Mission
Our mission is to bridge the gap between biospecimen donors and biomedical researchers, accelerating the pace of biomedical research by removing red tape, and reducing costs and delay of sample access. We ensure that the best quality science can be performed on our samples, through innovation and research on sample collection, characterization, storage, and distribution.
Who We Are
Greenfield Bio, Inc. comprises a distinguished collective of scholars, scientists, industry professionals, and students dedicated to propelling the pace of biomedical research. Our founders, with their esteemed affiliations to Harvard Medical School, Rice University, and MD Anderson Cancer Center, have firsthand experience with the challenges of translational research, often encountering delays of 6 to 12 months in an 18-month research period due to sample procurement from collaborators and suppliers. Dialogue with our academic associates and partners reveals that this delay is not an isolated concern but a pervasive obstacle faced by numerous researchers.
Remarkably, a drug's journey from discovery to FDA approval typically spans over a decade. Consider the profound societal impact if we could curtail biomedical research timelines by a significant 25% to 50%. This vision fuels our commitment, and we channel our collective knowledge, expertise, and resources to the mission of Greenfield Bio.
Our Work
1
Collection and Distribution
We collect blood and other biospecimens from disease survivors and their family members, who selflessly contribute to the advancement of medical knowledge so that all of humanity can benefit from longer, disease-free lives. Every sample is obtained with the utmost consideration for safety, privacy, consent, and data rights. All of our employees and volunteers undergo rigorous training when they first join the team, and receive refresher training every year. Furthermore, we conduct internal audits and follow-up with biospecimen contributors to ensure the rigor and professionalism of our processes.
2
Preservation and Banking
Once collected, contributed biospecimens are aliquoted into smaller vials and stored within our -80 ºC freezers. These freezers are connected to backup electrical generators to ensure that they will not be damaged even in occasional power outages. Our state-of-the-art laboratory information management systems (LIMS) ensure that the samples are barcoded and labeled accurately, to prevent labeling errors that may lead to inaccurate research results and conclusions.
Fair-Use Access
3
We want to make sure that the biospecimen samples are available to accelerate and democratize biomedical research, and do not all end up in the hands of big pharma. Consequently, we have an extensive Fair-Use Access policy in which sample access and pricing favors researchers that may traditionally have more limited financial resources. Our policy is updated on at least a yearly basis based on feedback from our donors, contributors, and volunteers.